Analysts expect Apogee Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.19 M | 1.60 M | 11.73 M | 14.25 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 M | 1.46 M | 10.42 M | 12.86 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.10 M | 1.53 M | 11.07 M | 13.55 M |
Analysts expect Apogee Therapeutics, Inc. to report earnings per share of -1.10 for Q3 26, against a range of -1.19 to -1.01. The most recent reported quarter, Q2 26, came in at -1.14 , in line with the -1.14 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.86 | -1.18 | -0.95 | -1.13 | -1.11 | -1.03 | -1.06 | -1.14 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.87 | -1.07 | -1.12 | -1.06 | -1.02 | -0.94 | -0.92 | -1.09 | -1.01 | -1.18 | -1.14 | -1.15 | -1.36 | -1.45 | -1.37 | -1.46 | ||||||||||
| Low Estimate | -0.95 | -1.19 | -1.26 | -1.22 | -1.18 | -1.08 | -1.10 | -1.19 | -1.19 | -1.26 | -1.22 | -1.27 | -1.50 | -1.59 | -1.67 | -1.78 | ||||||||||
| Consensus Estimate | -0.91 | -1.13 | -1.19 | -1.14 | -1.10 | -1.01 | -1.01 | -1.14 | -1.10 | -1.22 | -1.18 | -1.21 | -1.43 | -1.52 | -1.52 | -1.62 |
Pull Wall Street consensus for Apogee Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=APGE&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "APGE", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=APGE&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();